ALDESTA 15mg 15mg / ml injection solution in pre-filled syringe medication leaflet

L04AX03 methotrexate • Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants

Methotrexate is a medication used to treat various conditions, including autoimmune diseases and certain types of cancer. It is commonly prescribed for rheumatoid arthritis, severe psoriasis, psoriatic arthritis, and other chronic inflammatory diseases. It is also used in chemotherapy to treat leukemia, lymphomas, and other cancers.

Methotrexate works by inhibiting an enzyme called dihydrofolate reductase, which is essential for DNA synthesis and cell division. In autoimmune diseases, this mechanism helps reduce inflammation and immune system activity, while in cancer, it slows the growth of tumor cells.

Side effects may include nausea, vomiting, fatigue, mouth ulcers, hair loss, and a decrease in blood cell counts. In rare cases, more serious reactions can occur, such as liver damage, lung problems, or bone marrow suppression. It is crucial to take methotrexate as prescribed by a doctor, with regular blood tests to monitor for potential complications.

General data about ALDESTA 15mg 15mg / ml

Substance: methotrexate

Date of last drug list: 01-03-2020

Commercial code: W66410002

Concentration: 15mg / ml

Pharmaceutical form: injection solution in pre-filled syringe

Quantity: 4

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ACTAVIS ITALY S.P.A - ITALIA

Holder: ADDENDA PHARMA S.R.L. - ITALIA

Number: 12255/2019/02

Shelf life: 2 years

Concentrations available for methotrexate

100mg/ml, 10mg, 10mg/ml, 12.5mg, 12.5mg/ml, 15mg, 15mg/ml, 17.5mg, 17.5mg/ml, 2.5mg, 2.5mg/ml, 20mg, 20mg/ml, 22.5mg, 22.5mg/ml, 25mg, 25mg/ml, 27.5mg, 27.5mg/ml, 2mg/ml, 30mg, 30mg/ml, 50mg, 50mg/ml, 5mg, 5mg/ml, 7.5mg, 7.5mg/ml